The North America Medical Device Technologies Market was valued at USD 167,830 Million in 2025 and is projected to reach USD 312,450 Million by 2035, growing at a CAGR of 6.1% between 2024 and 2035. The market is driven by continuous technological advancements, increasing investment in healthcare infrastructure, and rising prevalence of chronic diseases. Key players such as Medtronic plc, Abbott Laboratories, and Boston Scientific Corporation continue to support the ecosystem with innovation and strategic collaborations.
The economic impact of tariffs on "North America Medical Device Technologies Market".
Market Growth Drivers
Rising Adoption of Minimally Invasive Devices: The growing preference for minimally invasive procedures among patients and healthcare providers is a significant growth driver for the North American market. Companies like Medtronic plc have been investing heavily in minimally invasive surgical devices, offering faster recovery times, reduced pain, and shorter hospital stays. This has resulted in increased adoption of products such as laparoscopic devices and catheter-based technologies across the United States and Canada.
Digital Health Integration and Remote Monitoring: The integration of digital health tools, including remote patient monitoring and telemedicine services, is transforming patient care. Abbott Laboratories, for instance, has expanded its remote cardiovascular monitoring tools, facilitating improved disease management beyond hospital settings. This technological advancement is fueling higher demand for connected and smart medical devices, supporting market growth.
Market Trends
Surge in Artificial Intelligence Applications: Artificial intelligence (AI) and machine learning are increasingly deployed in diagnostics, imaging, and surgical planning. GE Healthcare launched AI-powered imaging platforms that refine diagnostic accuracy and workflow efficiency. This trend is set to redefine patient outcomes and operational efficiency for North America's healthcare providers.
Growth of Wearable and Home Healthcare Devices: The popularity of wearable medical devices for continuous health tracking has risen sharply. Companies like Philips are introducing advanced health monitoring wearables for real-time glucose, cardiac, and respiratory data. The demand for home-based care and personal health monitoring solutions is propelling the wearable medical devices segment within the region.
Market Opportunity
Expansion in Geriatric Healthcare Technologies: With North America's rapidly aging population, there is an increasing opportunity to develop and commercialize technologies focused on elderly care. Stryker Corporation is targeting this segment by launching advanced orthopedic and mobility assistive devices tailored for elderly patients.
Emerging Markets Access: There is significant potential for medical device companies to expand their presence in underserved and rural areas of North America. Implementing mobile health units and point-of-care diagnostics, as championed by BD (Becton, Dickinson and Company), presents a substantial opportunity for market penetration and improved healthcare delivery.
North America Medical Device Technologies Market Revenue (USD Million), 2020-2035
The chart displays the steady growth of the North America Medical Device Technologies Market from 2020 to 2035. Starting at USD 125,800 Million in 2020, the market demonstrates robust compound annual growth, reflecting technological innovation, rising healthcare demands, and regulatory support for advanced medical devices. By 2025, revenues are estimated at USD 167,830 Million, progressing to USD 312,450 Million in 2035. This upward trajectory indicates strong expansion opportunities, driven by digital health adoption and an aging population demanding sophisticated healthcare solutions.
North America Medical Device Technologies Market Share by Region (%) - 2025
The 2025 pie chart shows that the United States dominates the North America Medical Device Technologies Market with a 74% share, attributed to its advanced healthcare infrastructure, strong R&D investments, and high adoption rates of innovative devices. Canada holds a 16% share, while Mexico accounts for 6%, driven by growing healthcare expenditure and efforts to modernize medical facilities. Emerging markets and rest of North America—including U.S. territories and small Caribbean islands—share the remaining 4%. This regional distribution highlights the concentration of technology agglomeration in the U.S., with gradual expansion to neighboring countries.
Recent Developments
In March 2024, Medtronic plc announced FDA approval for its next-generation Hugo™ robotic-assisted surgery (RAS) system in the United States, expanding minimally invasive surgery access and surgical precision. The approval underscores Medtronic’s commitment to innovation and strengthens its position in the surgical robotics market.
In April 2024, Abbott Laboratories launched an upgraded version of the FreeStyle Libre 3 continuous glucose monitoring (CGM) system in both the U.S. and Canada. This device offers real-time glucose readings, extended sensor wear, and direct smartphone integration, furthering the company’s leadership in diabetes management solutions.
In May 2024, Boston Scientific Corporation completed the acquisition of Relievant Medsystems, a company specializing in minimally invasive vertebral augmentation for chronic back pain. This acquisition broadens Boston Scientific’s chronic pain management portfolio and supports its strategy toward growth in innovative medical device markets.
Press Releases